Consolidated Income Statement in summary
Consolidated Balance Sheet in summary
Consolidated Cash Flow Statement in summary
Consolidated Statement of recognized income and expense
Change in Shareholders’ equity
Quarterly data
Sales by product area
Operating profit by product area
Operating margin by product area



| Consolidated Balance Sheet in summary | ||
| MSEK | Jun 30, 2008 Dec 31, 2007 | |
| Intangible assets | 4,081 | 4,419 |
| Property, plant and equipment | 2,306 | 2,388 |
| Financial fixed assets | 1,070 | 1,011 |
| Current operating assets | 4,868 | 5,204 |
| Other current investments | 5 | 5 |
| Cash and cash equivalents | 2,404 | 3,439 |
| Total assets | 14,735 | 16,467 |
| Equity attributable to equity holders of the Parent | –420 | 720 |
| Minority interest | 3 | 4 |
| Total equity | –417 | 724 |
| Non-current provisions | 1,326 | 1,292 |
| Non-current loans | 9,084 | 8,768 |
| Other non-current liabilities | 557 | 567 |
| Current provisions | 38 | 60 |
| Current loans | 1,011 | 1,271 |
| Other current liabilities | 3,136 | 3,785 |
| Total equity and liabilities | 14,735 | 16,467 |

| Consolidated Cash Flow Statement in summary | January–June | |
| MSEK | 2008 | 2007 |
| Profit before income taxes | 1,041 | 1,031 |
| Adjustments for non–cash items and other | 153 | 208 |
| Income tax paid | –346 | –325 |
| Cash flow from operating activities before changes in working capital | 848 | 914 |
| Cash flow from changes in working capital | –195 | –343 |
| Net cash from operating activities | 653 | 571 |
| Investing activities | ||
| Acquisition of property, plant and equipment* | –138 | –289 |
| Proceeds from sale of property, plant and equipment | 74 | 25 |
| Acquisition of intangible assets | –2 | –67 |
| Acquisition of subsidiaries, net of cash acquired | –6 | –365 |
| Divestment of business operations | 5 | – |
| Changes in financial receivables etc. | –4 | 38 |
| Changes in current investments | 0 | 51 |
| Net cash used in investing activities | –70 | –607 |
| Financing activities | ||
| Changes in loans | 102 | 743 |
| Dividends paid to equity holders of the Parent | –886 | –664 |
| Repurchase of own shares | –696 | –1,975 |
| Stock options exercised | 62 | 122 |
| Other | –116 | 39 |
| Net cash used in financing activities | –1,534 | –1,735 |
| Net decrease in cash and cash equivalents | –951 | –1,771 |
| Cash and cash equivalents at the beginning of the period | 3,439 | 3,042 |
| Effect of exchange rate fluctuations on cash and cash equivalents | –84 | 17 |
| Cash and cash equivalents at the end of the period | 2,404 | 1,288 |
| * Includes investments held for sale and biological assets | ||

| Consolidated Statement of Recognized | ||
| Income and Expense | January–June | |
| MSEK | 2008 | 2007 |
| Net profit for the period recognized in the income statement | 854 | 773 |
| Income and expenses recognized in equity: | ||
| Effective portion of changes in fair value of cash flow hedges | 42 | 32 |
| Translation difference in foreign operations | –519 | 22 |
| Tax on items taken to/transferred from equity | –12 | –9 |
| Total transactions taken to equity | –489 | 45 |
| Total income and expense recognized for the period | 365 | 818 |
| Attributable to: | ||
| Equity holders of the Parent | 364 | 818 |
| Minority interest | 0 | 0 |
| Total income and expense recognized for the period | 365 | 818 |

| Change in Shareholders’ Equity | January–June | |
| MSEK | 2008 | 2007 |
| Opening balance as per January 1 | 724 | 2,041 |
| Total income and expense recognized for the period | 365 | 818 |
| Repurchase of own shares | –696 | –1,975 |
| Stock options exercised | 62 | 122 |
| Share–based payments, IFRS 2 | 15 | 14 |
| Dividends paid to equity holders of the Parent | –886 | –664 |
| Cancellation of shares | –18 | – |
| Bonus issue | 18 | – |
| Minority interest | 0 | 0 |
| Closing balance as per June 30 | –417 | 356 |

| Income Statement in summary for Parent company | January–June | Full year | |
| MSEK | 2008 | 2007 | 2007 |
| Net sales | 1 | 6 | 6 |
| Cost of sales | 0 | –3 | –3 |
| Gross profit | 1 | 3 | 3 |
| Selling and administrative expenses | –168 | –131 | –351 |
| Operating loss | –167 | –128 | –348 |
| Income from participation in Group companies | 1,521 | 1 | 17,714 |
| Net finance cost | –752 | –134 | –368 |
| Profit after financial items | 602 | –262 | 16,998 |
| Appropriations | 0 | 0 | 11 |
| Profit before income tax | 602 | –262 | 17,009 |
| Income tax | 256 | 70 | 30 |
| Profit for the year | 858 | –192 | 17,039 |

| Balance Sheet in summary for Parent company | ||
| MSEK | Jun 30, 2008 Dec 31, 2007 | |
| Intangible and tangible assets | 12 | 19 |
| Financial fixed assets | 53,183 | 52,082 |
| Current assets | 4,693 | 7,381 |
| Total assets | 57,888 | 59,482 |
| Equity | 21,554 | 22,182 |
| Untaxed reserves | 13 | 13 |
| Non–current liabilities | 26,798 | 26,421 |
| Provisions | 38 | 20 |
| Current liabilities | 9,485 | 10,846 |
| Total liabilities | 36,334 | 37,300 |
| Total equity and liabilities | 57,888 | 59,482 |